Literature DB >> 30051174

Anaplastic changes of diffuse leptomeningeal glioneuronal tumor with polar spongioblastoma pattern.

Tomohiro Yamasaki1, Naoto Sakai2, Kazuya Shinmura3, Hiroshi Kawaji2, Shinichiro Koizumi2, Tetsuro Samashima2, Hiroki Namba2.   

Abstract

Diffuse leptomeningeal glioneuronal tumor (DLGNT) is a rare glioneuronal neoplasm with oligodendroglioma-like cells confined in the subarachnoid spaces. A great majority of DLGNT are histologically low grade. However, some tumors show features of anaplasia with increased mitotic and proliferative activity. Due to the limited number of patients and inadequate clinical follow-up reported to date, the WHO classification does not yet assign a distinct WHO grade to this entity. Polar spongioblastoma pattern, in which bipolar cells are arranged in parallel with palisading nuclei, remains poorly understood about the pathological process of forming this pattern. We experienced a case of 22-year-old man developing DLGNT with extensively distributed anaplastic changes involving polar spongioblastoma pattern and the secondary tumor invasion to brain parenchyma in 4½ years before the autopsy. Clinical and pathological courses of the patient are presented with radiological, histopathological, and genetic examinations. This is the first report demonstrating the immunohistological and genetic evaluation of a DLGNT with polar spongioblastoma pattern.

Entities:  

Keywords:  Anaplastic change; Autopsy; Diffuse leptomeningeal glioneuronal tumor; Polar spongioblastoma pattern

Mesh:

Year:  2018        PMID: 30051174     DOI: 10.1007/s10014-018-0326-z

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  8 in total

1.  Diffuse Leptomeningeal Glioneuronal Tumor of Childhood.

Authors:  D A Lakhani; K Mankad; S Chhabda; P Feizi; R Patel; A Sarma; S Pruthi
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-10       Impact factor: 3.825

Review 2.  Prognostic factors in diffuse leptomeningeal glioneuronal tumor (DLGNT): a systematic review.

Authors:  Karol Wiśniewski; Michael G Brandel; David D Gonda; John R Crawford; Michael L Levy
Journal:  Childs Nerv Syst       Date:  2022-07-22       Impact factor: 1.532

3.  Calcifications in diffuse leptomeningeal glioneuronal tumors: a case series.

Authors:  Giacomo Rebella; Claudia Milanaccio; Giovanni Morana; Domenico Tortora; Antonio Verrico; Gianluca Piatelli; Gabriele Gaggero; Paolo Nozza; Maria Luisa Garrè; Andrea Rossi; Mariasavina Severino
Journal:  Quant Imaging Med Surg       Date:  2022-05

4.  Diffuse Leptomeningeal Glioneuronal Tumour with 9-Year Follow-Up: Case Report and Review of the Literature.

Authors:  Milda Sarkinaite; Indre Devyziene; Jurgita Makstiene; Algimantas Matukevicius; Rymante Gleizniene
Journal:  Diagnostics (Basel)       Date:  2022-01-28

5.  Atypical and aggressive diffuse leptomeningeal glioneuronal tumor in a young adult: A case report and review of the literature.

Authors:  Domenico Policicchio; Riccardo Boccaletti; Angelo Salvatore Cuccu; Gina Casu; Giosuè Dipellegrini; Artan Doda; Giampiero Muggianu; Filippo Veneziani Santonio
Journal:  Surg Neurol Int       Date:  2022-05-20

Review 6.  Diffuse leptomeningeal glioneuronal tumour (DLGNT) with hydrocephalus as an initial symptom: a case-based update.

Authors:  Wenlin Chen; Ziren Kong; Ji Fu; Dachun Zhao; Renzhi Wang; Wenbin Ma; Yu Wang
Journal:  Childs Nerv Syst       Date:  2020-01-02       Impact factor: 1.475

Review 7.  Emerging glioneuronal and neuronal tumors: case-based review.

Authors:  So Dug Lim; Seong Ik Kim; Jin Woo Park; Jae Kyung Won; Seung-Ki Kim; Ji Hoon Phi; Chun-Kee Chung; Seung-Hong Choi; Hongseok Yun; Sung-Hye Park
Journal:  Brain Tumor Pathol       Date:  2022-01-20       Impact factor: 3.298

8.  A case of diffuse leptomeningeal glioneuronal tumor in a 10-year-old boy: First report from Iran.

Authors:  Parvaneh Karimzadeh; Yalda Nilipour; Mitra Khalili; Ali Nikkhah; Mehdi Taghavijelodar; Ehsan Moradi
Journal:  Clin Case Rep       Date:  2021-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.